LoginSignup
Grifols logo

Grifols

Stock
Stock
ISIN: ES0171996087
Ticker: GRF
ES0171996087
GRF

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 

$0.271

CHART BY

Frequently asked questions

What is Grifols's market capitalization?

The market capitalization of Grifols is $6.56B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Grifols's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Grifols is 106.16. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Grifols?

Grifols's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.241. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Grifols's stock?

Currently, 14 analysts cover Grifols's stock, with a consensus target price of $16.31. Analyst ratings provide insights into the stock's expected performance.

What is Grifols's revenue over the trailing twelve months?

Over the trailing twelve months, Grifols reported a revenue of $6.85B.

What is the EBITDA for Grifols?

Grifols's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.35B. EBITDA measures the company's overall financial performance.

How many employees does Grifols have, and what sector and industry does it belong to?

Grifols employs approximately 23,744 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of Grifols's shares?

The free float of Grifols is 291.12M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$6.56B
EPS (TTM) 
$0.241
Free Float 
291.12M
P/E ratio (TTM) 
106.16
Revenue (TTM) 
$6.85B
EBITDA (TTM) 
$1.35B

Pricing

1D span
$9.478$9.817
52W span
$6.908$17.61

Analyst Ratings

The price target is $16.31 and the stock is covered by 14 analysts.

Buy

10

Hold

3

Sell

1

Information

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Employees
23,744
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
ES0171996087
Primary Ticker
GRF

Knockouts

Join the conversation
Sign upLogin